Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry
Open Access
- 1 March 2019
- journal article
- research article
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 22, 102-104
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection FractionJAMA Cardiology, 2016
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection FractionJACC: Heart Failure, 2016
- Additional Prognostic Value of EAS index in predicting the occurrence of rehospitalizations in chronic heart failure: data from the Daunia Heart Failure RegistryEuropean Journal of Clinical Investigation, 2015
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart FailureNew England Journal of Medicine, 2014
- Heart Failure: Preventing Disease and Death WorldwideESC Heart Failure, 2014
- Epidemiology of Heart FailureCirculation Research, 2013
- Tissue Doppler Time Intervals Predict the Occurrence of Rehospitalization in Chronic Heart Failure: Data from the Daunia Heart Failure RegistryEchocardiography, 2012
- Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure RegistryClinics, 2011
- Cost-effectiveness Analysis in Clinical PracticeArchives of internal medicine (1960), 1999